Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M121,564Revenue $M45,698Net Margin (%)20.5Z-Score2.4
Enterprise Value $M147,490EPS $3.8Operating Margin %26.5F-Score7
P/E(ttm))13.9Cash Flow Per Share $4.7Pre-tax Margin (%)25.1Higher ROA y-yY
Price/Book11.010-y EBITDA Growth Rate %3.1Quick Ratio0.8Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %2.4Current Ratio1.1Lower Leverage y-yY
Price/Cash Flow9.3y-y EBITDA Growth Rate %-10.7ROA % (ttm)12.9Higher Current Ratio y-yY
Dividend Yield %5.1Insider Buy (3m)0ROE % (ttm)77.7Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M2,427ROI % (ttm)14.0Gross Margin Increase y-yN

Gurus Latest Trades with GSK

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GSKJohn Hussman 2014-03-31 Reduce-0.38%$50.9 - $56.66
($54)
$ 50.08-7%Reduce -23.61%323,500
GSKVanguard Health Care Fund 2014-03-31 Sold Out -0.11%$50.9 - $56.66
($54)
$ 50.08-7%Sold Out0
GSKJohn Hussman 2013-12-31 Add1.51%$49.31 - $53.68
($51.87)
$ 50.08-4%Add 1702.13%423,500
GSKCharles Brandes 2013-12-31 Add0.16%$49.31 - $53.68
($51.87)
$ 50.08-4%Add 13.11%2,145,461
GSKJoel Greenblatt 2013-12-31 Buy 0.11%$49.31 - $53.68
($51.87)
$ 50.08-4%New holding, 83452 sh.83,452
GSKVanguard Health Care Fund 2013-12-31 Reduce-0.14%$49.31 - $53.68
($51.87)
$ 50.08-4%Reduce -55.18%644,881
GSKWarren Buffett 2013-12-31 Sold Out -0.02%$49.31 - $53.68
($51.87)
$ 50.08-4%Sold Out0
GSKWarren Buffett 2013-09-30 Reduce-0.06%$50.27 - $52.96
($51.54)
$ 50.08-3%Reduce -76.57%345,819
GSKJoel Greenblatt 2013-06-30 Sold Out -0.16%$46.79 - $53.59
($50.77)
$ 50.08-1%Sold Out0
GSKVanguard Health Care Fund 2013-06-30 Reduce-0.1%$46.79 - $53.59
($50.77)
$ 50.08-1%Reduce -26.11%1,611,181
GSKJean-Marie Eveillard 2013-06-30 Reduce-0.05%$46.79 - $53.59
($50.77)
$ 50.08-1%Reduce -100%1
GSKJohn Hussman 2013-03-31 Reduce-0.57%$43.47 - $46.91
($44.97)
$ 50.0811%Reduce -95.51%23,500
GSKVanguard Health Care Fund 2013-03-31 Reduce-0.07%$43.47 - $46.91
($44.97)
$ 50.0811%Reduce -20.49%2,180,381
GSKJohn Hussman 2012-12-31 Add0.58%$41.9 - $47.45
($44.3)
$ 50.0813%Add 2584.62%523,500
GSKDodge & Cox 2012-12-31 Add0.18%$41.9 - $47.45
($44.3)
$ 50.0813%Add 5.08%63,302,825
GSKTweedy Browne 2012-12-31 Add0.03%$41.9 - $47.45
($44.3)
$ 50.0813%Add 20.16%151,264
GSKJoel Greenblatt 2012-12-31 Reduce-0.09%$41.9 - $47.45
($44.3)
$ 50.0813%Reduce -32.53%60,720
GSKJoel Greenblatt 2012-09-30 Buy 0.28%$44.25 - $47.23
($46.06)
$ 50.089%New holding, 89990 sh.89,990
GSKJean-Marie Eveillard 2012-03-31 Buy 0.06%$43.73 - $46.35
($42.21)
$ 50.0819%New holding, 322701 sh.322,701
GSKCharles Brandes 2011-12-31 Reduce-0.3%$40.53 - $45.74
($44)
$ 50.0814%Reduce -20.33%3,035,713
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GSK is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
GSK Charles Brandes 2014-03-312,164,2410.091.5+0.88%
GSK Jean-Marie Eveillard 2014-03-31100
GSK Joel Greenblatt 2014-03-3183,45200.07
GSK Dodge & Cox 2014-03-3160,386,5502.493.3-0.15%
GSK Tweedy Browne 2014-03-31142,5980.010.18-5.05%
GSK PRIMECAP Management 2014-03-319,177,8770.380.56-8.21%
GSK John Hussman 2014-03-31323,5000.011.3-23.61%
GSK Vanguard Health Care Fund 2014-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12317view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14257.43view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12317view

Press Releases about GSK :

    Quarterly/Annual Reports about GSK:

      News about GSK:

      Articles On GuruFocus.com
      Highest Yielding Stocks Widely Held By The Gurus Jul 01 2014 
      Diamond Hill Capital Comments on GlaxoSmithKline PLC Jun 26 2014 
      Major British Companies Lead Top Guru-Held UK and Ireland Stocks Jun 10 2014 
      Can Pfizer Make Up Its Loss? May 09 2014 
      Auxier Asset Management's Auxier Report - First Quarter 2014 May 06 2014 
      Weekly 52-Week Highs Highlight: AV, XEL, OKE, GSK Apr 28 2014 
      These Three Pharmaceutical Companies Shake The Market With Their Deal Apr 27 2014 
      GlaxoSmithKline Finally Received Approval from FDA for Its Diabetes Drug Tanzeum (Albiglutide) Apr 19 2014 
      Why Buy-and-Hold-Forever Buffett’s Company Just Sold Two Stocks Feb 27 2014 
      10 British Stocks to Consider Feb 20 2014 

      More From Our Partners
      Isis Pharma Initiates Phase II Study on ISIS-APO(a) - Analyst Blog Jul 21 2014 - ZACKS

      More From Other Websites
      Blocklisting Interim Review Jul 24 2014
      Is GlaxoSmithKline plc A Safe Dividend Investment? Jul 24 2014
      Is GlaxoSmithKline plc A Safe Dividend Investment? Jul 24 2014
      [$$] GlaxoSmithKline Reduces Full-Year Earnings Forecast Jul 23 2014
      Glaxosmithkline Reports Weak Sales and Cuts Outlook Jul 23 2014
      Glaxo’s Witty Has Bigger Problem Than China as Sales Sag Jul 23 2014
      China Bribery Probe, Dismal Advair Sales Leave Glaxo Shares Gasping Jul 23 2014
      Why GlaxoSmithKline (GSK) Stock Continues To Sink Today Jul 23 2014
      [video] GlaxoSmithKline Cuts Full-Year Outlook as Weak Advair Sales Weigh Jul 23 2014
      Glaxo slides in London after earnings warning Jul 23 2014
      [$$] U.S. Takes Wind Out of Glaxo's Sales Jul 23 2014
      Europe closes higher despite Ukraine tensions Jul 23 2014
      Should You Buy GlaxoSmithKline plc Or AstraZeneca plc? Jul 23 2014
      Should You Buy GlaxoSmithKline plc Or AstraZeneca plc? Jul 23 2014
      GSK Sees Fresh Air Ahead As Lung Drug Falters Jul 23 2014
      Glaxo Cuts 2014 Forecast on Sluggish U.S. Drug Sales Jul 23 2014
      Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising Jul 23 2014
      Why GlaxoSmithKline (GSK) Stock Is Falling Today Jul 23 2014
      GlaxoSmithKline plc Falls On Drop In Profits And Turnover Jul 23 2014
      GlaxoSmithKline plc Falls On Drop In Profits And Turnover Jul 23 2014

      Add Notes, Comments or Ask Questions

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK
      Email Hide